Open AccessRisk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery
Author(s) -
Shimin Hu,
Yong Hai,
Jiefu Tang,
Tao Liu,
Bing-Xin Liang,
Bo-Qiong Xue
Publication year - 2019
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000186
Subject(s) - medicine , orthopedic surgery , surgery
To prevent risk of life-threatening stent thrombosis, all patients need to undergo dual antiplatelet therapy (DAPT) for at least 6 weeks to 12 months after stent implantation. If DAPT is continued during noncardiac surgery, there is a risk of severe bleeding at the surgical site. Our study was to assess the risk of bleeding in patients with continued DAPT during orthopedic surgery.